Buparlisib Hydrochloride
Product Specifications
CAS Number
1312445-63-8
Target
Apoptosis, PI3K
Related Pathways
PI3K/Akt/mTOR signaling, Apoptosis
Purity
0.9894
Bioactivity
Buparlisib Hydrochloride (BKM120 HCl) is a specific and orally bioavailable pan-class I PI3K inhibitor that competitively inhibits PI3K/AKT kinase at the nanomolar level and suppresses cancer cell growth, making it suitable for studying breast cancer, glioblastoma, and solid tumours.
Smiles
Cl.FC(F)(F)C1=CC(=NC=C1C=2N=C(N=C(C2)N3CCOCC3)N4CCOCC4)N
Molecular Formula
C18H22ClF3N6O2
Molecular Weight
446.85
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2087602 1.0 µg DNA
SAMD11 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details 
355888-01 48 Tests
GCLC (Glutamate--cysteine ligase catalytic subunit) BioAssayTM ELISA Kit (Human) discontinued
Sign In for Pricing
View Details 355888-02 96 Tests
GCLC (Glutamate--cysteine ligase catalytic subunit) BioAssayTM ELISA Kit (Human) discontinued
Sign In for Pricing
View Details C2390-25B 500 µg
CD38 (Acute Lymphoblastic Leukemia Cells Antigen, ADP Ribosyl Cyclase, CADPr Hydrolase 1, Cyclic ADP Ribose Hydrolase, Ecto Nicotinamide Adenine Dinucleotide Glycohydrolase, I19 (Mouse), Lymphocyte Differentiation Antigen) (FITC)
Sign In for Pricing
View Details LV751546 1.0 µg DNA
TRNAD17 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details